Mirko Čolić

ORCID: 0000-0003-1447-308X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Cardiac Health and Mental Health
  • Acute Myocardial Infarction Research
  • Atrial Fibrillation Management and Outcomes
  • Coronary Interventions and Diagnostics
  • COVID-19 and Mental Health
  • Inflammatory mediators and NSAID effects
  • Cardiac Valve Diseases and Treatments
  • Cardiovascular Function and Risk Factors
  • Biosimilars and Bioanalytical Methods
  • Global Public Health Policies and Epidemiology
  • Lipoproteins and Cardiovascular Health
  • Pharmaceutical Practices and Patient Outcomes
  • Exercise and Physiological Responses
  • Venous Thromboembolism Diagnosis and Management
  • Cardiac Ischemia and Reperfusion
  • Veterinary Practice and Education Studies
  • Cardiovascular and exercise physiology
  • Healthcare Quality and Management
  • Long-Term Effects of COVID-19
  • Cardiac Imaging and Diagnostics

Institute for Cardiovascular Diseases of Vojvodina
2008-2025

Abstract Objectives: The aim of this study was to assess the pharmacokinetics and tolerability Biolimus A9 eluted from Nobori coronary stents. Background: release kinetics drugs delivered via stents have been shown play an essential role in efficacy safety drug eluting Methods: Twenty patients with artery disease were treated single 14‐mm (10 patients) or 28‐mm long stent patients). Blood samples drawn at 16 time points determine A9. At seven points, complete laboratory toxicology panels...

10.1002/ccd.21775 article EN Catheterization and Cardiovascular Interventions 2008-10-27

Abstract Background and Aims Remnant cholesterol in triglyceride-rich lipoproteins is associated observationally causally with increased risk of atherosclerotic cardiovascular disease. We aimed to evaluate attainment guideline recommended targets for lipid lowering treatment, blood pressure physical activity level patients documented disease its relation EUROASPIRE score (for Serbian population) as well the remnant cholesterol. Methods Patients who were included The SUrvey CVD Risk Factors...

10.1093/eurjpc/zwaf236.232 article EN European Journal of Preventive Cardiology 2025-05-01

AbstractObjective This study on responsiveness to clopidogrel and aspirin evaluates its interaction with: (i) patient characteristics; (ii) procedure (iii) antiplatelet dose.Methods results After elective PCI, 60 patients receiving 100 mg daily, 75mg daily were monitored with the PFA test VASP assay.Non-responsiveness was found in 23 (38%) 18 (30%) of patients, respectively. Seven (12%) dual nonresponders. Non-responders both more often smokers. clopidogrel, addition had elevated infl...

10.1080/ac.66.3.2114133 article EN Acta Cardiologica 2011-06-01

This study on responsiveness to clopidogrel and aspirin evaluates its interaction with: (i) patient characteristics; (ii) procedure (iii) antiplatelet dose.After elective PCI, 60 patients receiving 100 mg daily, 75 daily were monitored with the PFA test VASP assay. Non-responsiveness was found in 23 (38%) 18 (30%) of patients, respectively. Seven (12%) dual nonresponders. Non-responders both more often smokers. clopidogrel, addition had elevated inflammatory markers (P < 0.05). Dual...

10.2143/ac.66.3.2114133 article EN PubMed 2011-06-01

Background Bleeding after percutaneous coronary interventions (PCI) is an important complication with impact on prognosis. Aim To evaluate the predictive value of enhanced platelet responsiveness to dual antiplatelet therapy aspirin and clopidogrel, for bleeding, elective PCI. Methods Results We performed multiple electrode aggregometry (MAE) functional tests induced by arachidonic acid (ASPI) adenosine‐diphosphate (ADP) before PCI, 24 hours in 481 PCI patients who were followed‐up average...

10.1111/joic.12251 article EN Journal of Interventional Cardiology 2015-12-01

Abstract Funding Acknowledgements Type of funding sources: None. Background Cardiac rehabilitation (CR) is a class I treatment for cardiovascular disease, still, underutilization these services remains. During the coronavirus 2019 (COVID-19) pandemic, an even greater gap in CR care has been present. Purpose and methods We aimed to present cardiac during COVID 19 times Belgrade. At beginning epidemic Serbia number patients in-house city program was 70 out beds, with 200 who were scheduled (on...

10.1093/eurjpc/zwab061.327 article EN other-oa European Journal of Preventive Cardiology 2021-05-01

Purpose Velocity propagation (Vp) of early diastole is a known method for the evaluation left ventricular (LV) diastolic function. Our purpose was to determine whether Vp valuable tool characterize patients after acute myocardial infarction and LV remodelling (LVR). Methods M-mode, two-dimensional Doppler echocardiography were performed in 71 within first 2 days, 1, 3 6 months infarction. We measured atrium, diameters volumes, peak late velocity (E, A) deceleration time, Vp, annular (e)...

10.1097/mca.0b013e328316e955 article EN Coronary Artery Disease 2009-03-01
Coming Soon ...